UB Paderborn / Katalog / Suche / in CDI

Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how?

Bone marrow transplantation (Basingstoke), 2014-01, Vol.49 (1), p.1-7

2014

Volltextzugriff (PDF)

Eltrombopag after allogeneic haematopoietic cell transplantation in a case of poor graft function and systematic review of the literature

Transfusion medicine (Oxford, England), 2016-06, Vol.26 (3), p.202-207

2016

Volltextzugriff (PDF)

Evaluating dose-limiting toxicities of MDM2 inhibitors in patients with solid organ and hematologic malignancies: A systematic review of the literature

Leukemia research, 2019-11, Vol.86, p.106222-106222, Article 106222

2019

Volltextzugriff (PDF)

Total Body Irradiation in Relapsed Follicular Lymphoma: Outcomes and Early Toxicity

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E498-E499

2016

Volltextzugriff (PDF)

First-line therapy, autologous stem-cell transplantation, and post-transplantation maintenance in the management of newly diagnosed mantle cell lymphoma

Current oncology (Toronto), 2020-12, Vol.27 (6), p.e632-644

2020

Volltextzugriff (PDF)

PO-0667: Second malignancies after TBI in AHCT for relapsed follicular lymphoma

Radiotherapy and oncology, 2016-04, Vol.119, p.S311-S311

2016

Volltextzugriff (PDF)

Plerixafor for autologous stem-cell mobilization and transplantation for patients in Ontario

Current oncology (Toronto), 2016-08, Vol.23 (4), p.e409-430

2016

Volltextzugriff (PDF)

Pulmonary Toxicity Following Total Body Irradiation for Acute Lymphoblastic Leukemia: The Ottawa Hospital Cancer Centre (TOHCC) Experience

International journal of radiation oncology, biology, physics, 2013-10, Vol.87 (2), p.S557-S558

2013

Volltextzugriff (PDF)

Network geometry of evidence from randomised controlled trials addressing donor selection and source of haematopoietic progenitor cells used in allogeneic transplantation: a systematic scoping review

Transfusion medicine (Oxford, England), 2018-10, Vol.28 (5), p.371-379

2018

Volltextzugriff (PDF)

Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes

Current oncology (Toronto), 2020-12, Vol.27 (6), p.e596-606

2020

Volltextzugriff (PDF)

Mobilizing Autologous Hematopoietic Stem Cells in Patients with Myeloma: A Economic Comparison of 4 Common Mobilization Strategies

Value in health, 2014-05, Vol.17 (3), p.A84-A84

2014

Volltextzugriff (PDF)

Pulmonary toxicity following total body irradiation for acute lymphoblastic leukaemia: The Ottawa Hospital Cancer Centre (TOHCC) experience

Journal of radiotherapy in practice, 2016-03, Vol.15 (1), p.54-60

2016

Volltextzugriff (PDF)

Extracorporeal photopheresis in the management of graft-versus-host disease

Current oncology (Toronto), 2014-04, Vol.21 (2), p.e310-e325

2014

Volltextzugriff (PDF)

Rapamycin enriches for CD4+ CD25+ CD27+ Foxp3+ regulatory T cells in ex vivo -expanded CD25-enriched products from healthy donors and patients with multiple sclerosis

Cytotherapy (Oxford, England), 2007, Vol.9 (2), p.144-157

2007

Volltextzugriff (PDF)

Ionospheric Signatures of ULF Waves: Passive Radar Techniques

Magnetospheric ULF Waves: Synthesis and New Directions, 2006, p.259-271

2006

Volltextzugriff (PDF)

Steady-state end-tidal alveolar dead space fraction and D-dimer: Bedside tests to exclude pulmonary embolism

Chest, 2001-07, Vol.120 (1), p.115-119

2001

Volltextzugriff (PDF)

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

Blood advances, 2022-01, Vol.6 (1), p.339-357

2022

Volltextzugriff (PDF)

Reduced intensity conditioned allograft yields favorable survival for older adults with B‐cell acute lymphoblastic leukemia

American journal of hematology, 2017-01, Vol.92 (1), p.42-49

2017

Volltextzugriff (PDF)

High Dose Total Body Irradiation for Refractory Acute Myeloid Leukemia

International journal of radiation oncology, biology, physics, 2017-10, Vol.99 (2), p.S179-S179

2017

Volltextzugriff (PDF)

Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

The New England journal of medicine, 1999-07, Vol.341 (1), p.14-21

1999

Volltextzugriff (PDF)

PCN94 - Mobilizing Autologous Hematopoietic Stem Cells in Patients with Myeloma: A Economic Comparison of 4 Common Mobilization Strategies

Value in health, 2014-05, Vol.17 (3), p.A84-A84

2014

Volltextzugriff (PDF)

First-Line Therapy, Autologous Stem-Cell Transplantation, and Post-Transplantation Maintenance in the Management of Newly Diagnosed Mantle Cell Lymphoma

Current oncology (Toronto), 2020-12, Vol.27 (6), p.632

2020

Volltextzugriff (PDF)

Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee

Biology of blood and marrow transplantation, 2016-11, Vol.22 (11), p.1915-1925

2016

Volltextzugriff (PDF)

Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes

Transplantation and cellular therapy, 2021-11, Vol.27 (11), p.921.e1-921.e10

2021

Volltextzugriff (PDF)

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML

Blood advances, 2022-02, Vol.6 (3), p.828-847

2022

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how?

Eltrombopag after allogeneic haematopoietic cell transplantation in a case of poor graft function and systematic review of the literature

Evaluating dose-limiting toxicities of MDM2 inhibitors in patients with solid organ and hematologic malignancies: A systematic review of the literature

Total Body Irradiation in Relapsed Follicular Lymphoma: Outcomes and Early Toxicity

First-line therapy, autologous stem-cell transplantation, and post-transplantation maintenance in the management of newly diagnosed mantle cell lymphoma

PO-0667: Second malignancies after TBI in AHCT for relapsed follicular lymphoma

Plerixafor for autologous stem-cell mobilization and transplantation for patients in Ontario

Pulmonary Toxicity Following Total Body Irradiation for Acute Lymphoblastic Leukemia: The Ottawa Hospital Cancer Centre (TOHCC) Experience

Network geometry of evidence from randomised controlled trials addressing donor selection and source of haematopoietic progenitor cells used in allogeneic transplantation: a systematic scoping review

Pre-Transplant Marital Status and Hematopoietic Cell Transplantation Outcomes

Mobilizing Autologous Hematopoietic Stem Cells in Patients with Myeloma: A Economic Comparison of 4 Common Mobilization Strategies

Pulmonary toxicity following total body irradiation for acute lymphoblastic leukaemia: The Ottawa Hospital Cancer Centre (TOHCC) experience

Extracorporeal photopheresis in the management of graft-versus-host disease

Rapamycin enriches for CD4+ CD25+ CD27+ Foxp3+ regulatory T cells in ex vivo -expanded CD25-enriched products from healthy donors and patients with multiple sclerosis

Ionospheric Signatures of ULF Waves: Passive Radar Techniques

Steady-state end-tidal alveolar dead space fraction and D-dimer: Bedside tests to exclude pulmonary embolism

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

Reduced intensity conditioned allograft yields favorable survival for older adults with B‐cell acute lymphoblastic leukemia

High Dose Total Body Irradiation for Refractory Acute Myeloid Leukemia

Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

PCN94 - Mobilizing Autologous Hematopoietic Stem Cells in Patients with Myeloma: A Economic Comparison of 4 Common Mobilization Strategies

First-Line Therapy, Autologous Stem-Cell Transplantation, and Post-Transplantation Maintenance in the Management of Newly Diagnosed Mantle Cell Lymphoma

Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee

Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes

Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML

Aktive Filter

Suchergebnisse filtern